CD28 and renal cell carcinoma: Costimulation using CD28 increased markers of activation and effector function in patient RCC TILs in a pattern similar to that observed in prior studies with preclinical and patient samples of other tumor types showing that costimulation using CD28 or 4-1BB can increase antitumor activity (7, 42, 43).